INS and type 2 diabetes mellitus: In the people with type 2 diabetes in this study, who despite of more than 13 years diabetes duration and ten years of insulin therapy had preserved endogenous insulin secretion as reflected by measurable C-peptide levels, the glucagon response to hypoglycaemia was in line with that of the control group.